cancer

New cancer 'wonder' drugs trigger cancer spread to bones

Wednesday, February 20, 2013 by: Sherry Baker, Health Sciences Editor
Tags: cancer drugs, IAP antagonists, spreading tumors

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Russia taking McDonald's to court, threatens countrywide shutdown
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Why does the CDC own a patent on Ebola 'invention?'
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Oregon man serving prison sentence for collecting rainwater on his own property
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Diet soda, aspartame linked to premature deaths in women
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Harvard research links fluoridated water to ADHD, mental disorders
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Delicious
(NaturalNews) Most cancer drugs are used to hopefully kill tumors and keep malignancies from spreading. Unfortunately, new research from the Washington University School of Medicine in St. Louis raises serious concerns that Big Pharma's highly touted class of cancer drugs known as IAP antagonists actually increases the risk of tumors spreading to bone.

"These investigational drugs are getting broad attention right now because they seem to be very effective against primary tumors," senior author Deborah V. Novack, MD, PhD, associate professor of medicine, said in a media statement "There is also excitement because until now, these drugs have not appeared to have major side effects."

However, the study by Novack and her research team (just published in the journal Cancer Discovery) reveals that while the IAP drugs target a protein that makes tumors vulnerable to death, the same protein also over-activates cells called osteoclasts which are responsible for tearing down bone. The risk for patients? Potentially, IAPs can trigger the bone weakening disease osteoporosis and, even more worrisome, they may cause metastasis of cancer to the bones.

Numerous IAP antagonists are already in early clinical trials against breast, lung, pancreatic, ovarian, prostate, liver, skin and blood cancers. While these phase one or two clinical trials look at the short-term safety and effectiveness of new drugs, the researchers say they may not catch bone metastasis. "These trials do not necessarily look for long-term effects of the drugs," Chang Yang, MD, PhD, staff scientist and the paper's first author said in the press statement. "If the cancer is going to metastasize to bone, it may take six months to two years to see that outcome. This may not be seen during the clinical trial."

Due to the study's findings, Novack has gone on record urging cancer specialists oncologists to consider protecting the bones in people taking IAP antagonists, including patients with cancers that don't typically spread to bone. "For many of these cancers, doctors are not watching bone," Novack says. "Osteoporosis is not the biggest concern when treating cancer, but if they're not doing bone scans, they may miss a cancer spreading to bone."

Normally, osteoclasts work alongside other normal cells to build new bone. But because IAP antagonists over-activate osteoclasts, bone ends up being destroyed and not replaced. Working with experiments on mice, the scientists showed that the drug led to osteoporosis and created an environment that encouraged tumor growth in degrading bone, even while killing breast cancer cells in other parts of the animals' bodies.

As Natural News has previously reported, other cancer drugs have also been found to possibly promote the disease they are supposed to fight. For example, according to findings published in the Proceedings of the National Academy of Science by researchers at the George Whipple Laboratory for Cancer Research at the University of Rochester Medical Center, hormone therapy for prostate cancer can cause a revving up of other prostate cell growth and lead to a proliferation of cancer cells in the future. In addition, researchers with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Department of Chemistry were awarded an $805,000 grant from the U.S. Department of Defense Breast Cancer Research Program in 2010. The goal? To investigate the very real possibility that dead cancer cells left over after chemotherapy spark cancer to spread to other parts of the body.

Editor's note: Natural News is opposed to the use of animals in medical experiments that expose them to harm. We present these findings in protest of the way in which they were acquired.

Sources:

http://news.wustl.edu/news/Pages/24916.aspx
http://www.naturalnews.com/034099_prostate_cancer_treatments.html
http://www.naturalnews.com/029042_cancer_cells_chemotherapy.html

About the author:
Sherry Baker is a widely published writer whose work has appeared in Newsweek, Health, the Atlanta Journal and Constitution, Yoga Journal, Optometry, Atlanta, Arthritis Today, Natural Healing Newsletter, OMNI, UCLA''''s "Healthy Years" newsletter, Mount Sinai School of Medicine''''s "Focus on Health Aging" newsletter, the Cleveland Clinic''''s "Men''''s Health Advisor" newsletter and many others.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.